Industry Overview

Biomaterials market, valued at $45.1 billion in 2025, is projected to reach $85.3 billion by 2035, expanding at a CAGR of 6.7%. Biomaterials are integral to modern healthcare, enabling the development of implants, prosthetics, and regenerative solutions across orthopedic, cardiovascular, and dental applications. Rising incidences of chronic diseases, coupled with aging populations, are driving demand for advanced biomaterials that offer improved biocompatibility, durability, and performance. Innovations in tissue engineering and nanotechnology are further enhancing the integration of biomaterials with human tissues, supporting more effective patient outcomes. Growing healthcare expenditure and the adoption of high-performance, customized solutions are also key factors propelling long-term market growth. Leading players are expanding their capabilities to meet evolving clinical needs, while advancements in 3D printing and polymeric biomaterials continue to diversify applications in regenerative medicine and surgical devices.

Industry developments highlight the focus on innovation and precision in biomaterials and orthopedic solutions. In February 2026, Zimmer Biomet is set to showcase new clinical data and advanced technologies at the AAOS Annual Meeting 2026, featuring ROSA Knee, Persona IQ smart implant, and AI-driven surgical tools, with Arnold Schwarzenegger appearing as the Presidential Guest Speaker. Similarly, in September 2025, Stryker Corporation launched its FDA-cleared Incompass Total Ankle System at the AOFAS Annual Meeting 2025, offering 3D-printed implants and flexible instrumentation to simplify procedures and enhance long-term outcomes. These technological advancements, alongside expanding manufacturing capabilities and specialized biomaterials strategies, underscore the market’s shift toward personalized, high-performance solutions that improve patient recovery and surgical efficiency, reinforcing sustained growth in the biomaterials sector.

Market Dynamics

Metallic Biomaterials Lead Orthopedic Innovation

Metallic biomaterials, particularly titanium alloys, continue to dominate the orthopedic implant market due to their superior strength, durability, and biocompatibility. Titanium alloys offer high tensile strength, corrosion resistance, and excellent osseointegration, making them ideal for load-bearing applications such as hip, knee, and shoulder implants. Their long-term reliability has made them the material of choice for surgical procedures worldwide. According to the Organisation for Economic Co-operation and Development (OECD) Health Briefly: Europe 2024, hip and knee replacement procedures across European countries have steadily increased, reflecting the growing demand for orthopedic care among aging populations and the rising prevalence of musculoskeletal disorders. In March 2025, Zimmer Biomet highlighted its latest metallic biomaterial innovations at the AAOS 2025 Annual Meeting, showcasing advanced hip, knee, and upper extremity implants, including the Z1 Femoral Hip System and Persona OsseoTi Keel Tibia. Additionally, the company introduced the ZBX Ambulatory Surgery Center program, aimed at improving surgical efficiency, streamlining workflows, and enhancing patient outcomes. These initiatives underscore the continued leadership of Zimmer Biomet in high-performance orthopedic solutions, emphasizing metal implants as a central growth driver.

Polymeric Biomaterials Lead Growth with 3D-Printed Cardiovascular Stents

Polymeric biomaterials are the fastest-growing segment in the biomaterials market, primarily driven by their versatility and expanding use in cardiovascular stents and tissue engineering applications. Polymers such as polylactic acid (PLA), polyglycolic acid (PGA), and polycaprolactone (PCL) offer biodegradability, biocompatibility, and mechanical flexibility, which make them ideal for next-generation implants. According to a study published on PubMed Central, titled “Additive Manufacturing of Polymeric Bioresorbable Stents: A Mechanical Performance Perspective”, 3D printing is revolutionizing the production of polymer-based bioresorbable stents. Additive manufacturing enables patient-specific, biodegradable designs that improve biocompatibility, reduce dependence on traditional metallic implants, and allow for customized geometries to match individual vascular anatomies. While challenges remain in mechanical performance and long-term stability, additive manufacturing techniques are paving the way for next-generation cardiovascular solutions with enhanced clinical outcomes.

In March 2025, Evonik Industries expanded its production capacity for medical-grade polymers to support the growing demand for bioresorbable polymeric implants. This expansion reflects the strategic focus on polymeric biomaterials as a high-growth segment, targeting tissue engineering, wound healing, and cardiovascular applications. The rapid adoption of polymeric biomaterials in 3D printing and additive manufacturing further increases their share of global biomaterials revenue.

Market Segmentation

• Based on the material type, the market is segmented into metallic, polymeric, ceramic, and composite.
• Based on the application, the market is segmented into orthopaedic, cardiovascular, dental, neurological, ophthalmic, wound healing & tissue engineering.

Orthopaedic: A Segment in Market Growth

Orthopaedics continues to dominate the biomaterials application landscape, driven by rising joint replacement procedures and the growing prevalence of musculoskeletal disorders globally. In March 2026, Smith Nephew will highlight its advanced rotator cuff repair portfolio at the AAOS Annual Meeting 2026 in New Orleans. Featured technologies include the Tendon Seam Repair System and REGENETEN Bioinductive Implant, designed to strengthen repairs, promote tissue healing, and reduce re-tear rates. These innovations underscore the segment’s shift toward high-performance, patient-centred solutions that enhance surgical precision and long-term musculoskeletal health, reflecting broader trends in the orthopaedic biomaterials market.

Regional Outlook

The global biomaterials market is further divided by region, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

North America is the leading region in the Market

North America leads the global biomaterials market due to its advanced healthcare infrastructure, high adoption of innovative medical technologies, and strong regulatory framework. The region benefits from significant healthcare expenditure, particularly in the United States, which drives widespread adoption of advanced implants and biomaterial-based devices. The U.S. accounts for a major share of global orthopaedic and cardiovascular procedures, supported by the increasing prevalence of chronic diseases and an aging population. Favourable reimbursement policies and continuous technological advancements further strengthen market growth. In January 2026, Boston Scientific announced the acquisition of Penumbra, Inc. in a cash and stock deal valued at approximately $14.5 billion. This strategic move expands Boston Scientific’s capabilities in vascular and neurovascular therapies, including thrombectomy devices used for stroke and blood clot treatment. The acquisition enhances the company’s presence in high-growth cardiovascular segments and supports innovation in minimally invasive procedures. Overall, North America continues to dominate due to strong clinical demand, technological leadership, and strategic investments by key industry players.

Market Players Outlook

The major companies operating in the global biomaterials market include Zimmer Biomet, Stryker Corporation, DePuy Synthes, Smith & Nephew, and Medtronic, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain market positioning. Strategic investments in additive manufacturing, 3D printing, and polymeric biomaterial technologies are enhancing competitive differentiation.

Recent Development

• In September 2025, Stryker Corporation launched its Incompass Total Ankle System at the AOFAS Annual Meeting, introducing an advanced implant platform for patients with end-stage ankle arthritis.

• In April 2024, Evonik Industries expanded its production capacity for customized RESOMER powder biomaterials to meet growing demand in medical devices and drug delivery applications. The expansion supports advanced bioresorbable polymers used in implants, enabling greater design flexibility and improved patient-specific treatment solutions.

The Report Covers
·         Market value data analysis of 2025 and forecast to 2035.
·         Annualized market revenues ($ million) for each market segment.
·         Country-wise analysis of major geographical regions.
·         Key companies operating in the global biomaterials Market.
·         Based on the availability of data, information related to new products and relevant news is also available in the report.
·         Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
·         Analysis of market-entry and market expansion strategies.
·         Competitive strategies by identifying ‘who-stands-where’ in the market.